The goals of the Genotyping Core are to promote and facilitate the research undertaken by the Program Investigators, as well as to enhance interdisciplinary research capabilities. The Genotyping Core will provide support in terms of equipment and expertise related to the very sophisficated technology needed for the success of the Projects, including all equipment and methods needed for single nucleofide polymorphism (SNP) genotyping and SNP arrays. The Genotyping Core will be an integral part of the research team in the development and execution of research studies;as well as providing ongoing analytical and procedural advice throughout the life of each individual Project.
The specific aims of the Genotyping Core include:
Specific Aim 1 : Facilitate MHC genotyping for Project 1 Specific Aim 2: Provide genotyping support and services to complete genome-wide association studies (GWAS) Specific Aim 3: Provide genotyping support and services to complete the proposed fine-mapping and replication studies.

Public Health Relevance

The studies proposed in this POI include 3 genome-wide association studies and follow-up fine-mapping and replication. The expertise provided by the Genotyping core in the technologies required for this work is highly relevant to the overall objectives of the Program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI083194-05
Application #
8514486
Study Section
Special Emphasis Panel (ZAI1-KS-I)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
5
Fiscal Year
2013
Total Cost
$217,196
Indirect Cost
$33,427
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
077333797
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Kariuki, S N; Ghodke-Puranik, Y; Dorschner, J M et al. (2015) Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus. Genes Immun 16:15-23
Morris, D L; Fernando, M M A; Taylor, K E et al. (2014) MHC associations with clinical and autoantibody manifestations in European SLE. Genes Immun 15:210-7
Freedman, Barry I; Langefeld, Carl D; Andringa, Kelly K et al. (2014) End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol 66:390-6
Armstrong, D L; Zidovetzki, R; Alarcón-Riquelme, M E et al. (2014) GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region. Genes Immun 15:347-54
Dozmorov, Mikhail G; Wren, Jonathan D; Alarcon-Riquelme, Marta E (2014) Epigenomic elements enriched in the promoters of autoimmunity susceptibility genes. Epigenetics 9:276-85
Harley, John B; Zoller, Erin E (2014) Editorial: What caused all these troubles, anyway? Epstein-Barr virus in Sjögren's syndrome reevaluated. Arthritis Rheumatol 66:2328-30
Guthridge, Joel M; Lu, Rufei; Sun, Harry et al. (2014) Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. Am J Hum Genet 94:586-98
Kottyan, Leah C; Davis, Benjamin P; Sherrill, Joseph D et al. (2014) Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet 46:895-900
Lu-Fritts, Pai-Yue; Kottyan, Leah C; James, Judith A et al. (2014) Association of systemic lupus erythematosus with uranium exposure in a community living near a uranium-processing plant: a nested case-control study. Arthritis Rheumatol 66:3105-12
Kim-Howard, Xana; Sun, Celi; Molineros, Julio E et al. (2014) Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations. Hum Mol Genet 23:1656-68

Showing the most recent 10 out of 47 publications